Dimensional Fund Advisors
WHWK

Dimensional Fund Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Dimensional Fund Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
33,420
+3,330
+11% +$13.9K ﹤0.01% 3103
2026
Q1 		$104K Buy
30,090
+1,449
+5% +$4.54K ﹤0.01% 3113
2025
Q4 		$69.3K Sell
28,641
-15,474
-35% -$35.5K ﹤0.01% 3190
2025
Q3 		$83.8K Sell
44,115
-26,634
-38% -$49K ﹤0.01% 3206
2025
Q2 		$132K Sell
70,749
-36,771
-34% -$64K ﹤0.01% 3160
2025
Q1 		$192K Buy
107,520
+71,925
+202% +$188K ﹤0.01% 3136
2024
Q4 		$112K Hold
35,595
– – ﹤0.01% 3231
2024
Q3 		$73.2K Sell
35,595
-61
-0.2% -$99 ﹤0.01% 3263
2024
Q2 		$52.2K Buy
35,656
+61
+0.2% +$113 ﹤0.01% 3311
2024
Q1 		$83.3K Hold
35,595
– – ﹤0.01% 3280
2023
Q4 		$72K Sell
35,595
-15,660
-31% -$65.7K ﹤0.01% 3312
2023
Q3 		$248K Sell
51,255
-23,437
-31% -$136K ﹤0.01% 3181
2023
Q2 		$511K Sell
74,692
-14,610
-16% -$114K ﹤0.01% 3061
2023
Q1 		$646K Buy
+89,302
New +$954K ﹤0.01% 2987
2021
Q3 		– Sell
-1,026
Closed -$26K – 3539
2021
Q2 		$26K Hold
1,026
– – ﹤0.01% 3456
2021
Q1 		$20K Sell
1,026
-581
-36% -$13.4K ﹤0.01% 3406
2020
Q4 		$24K Buy
+1,607
New +$34.4K ﹤0.01% 3340

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's WHWK Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Whitehawk Therapeutics (WHWK) stake by 11% in Q2 2026, buying an estimated $13.9K and bringing the position to 33,420 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

Dimensional Fund Advisors first reported a position in WHWK in Q4 2020 and has held it in 17 quarters since. The position peaked at $646K in Q1 2023. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Dimensional Fund Advisors held 33,420 shares of Whitehawk Therapeutics worth $153K as of Q2 2026.
  • Dimensional Fund Advisors bought 3,330 Whitehawk Therapeutics shares in Q2 2026, an estimated $13.9K.
  • Whitehawk Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3103 holding.
  • Dimensional Fund Advisors first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Whitehawk Therapeutics position peaked at $646K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.